Home > Annual Financials > NEULAND LABORATORIES

NEULAND LABORATORIES Financial Statement Analysis
[BOM: 524558|NSE : NEULANDLAB]

The Revenues of NEULAND LABORATORIES have decreased by -5.24% YoY .
The Earnings Per Share (EPS) of NEULAND LABORATORIES has decreased by -13.32 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

NEULAND LABORATORIES Last 5 Annual Financial Results
[BOM: 524558|NSE : NEULANDLAB]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹1,477 Cr₹1,559 Cr₹1,191 Cr₹951 Cr₹937 Cr
Expenses ₹1,154 Cr₹1,096 Cr₹919 Cr₹808 Cr₹790 Cr
Operating Profit (Excl OI) ₹323 Cr₹463 Cr₹272 Cr₹143 Cr₹147 Cr
Other Income ₹21 Cr₹13 Cr₹9.75 Cr₹2.08 Cr₹16 Cr
Interest ₹8.30 Cr₹14 Cr₹13 Cr₹13 Cr₹18 Cr
Depreciation ₹66 Cr₹60 Cr₹53 Cr₹49 Cr₹40 Cr
Profit Before Tax ₹346 Cr₹401 Cr₹216 Cr₹82 Cr₹105 Cr
Profit After Tax ₹260 Cr₹300 Cr₹164 Cr₹64 Cr₹81 Cr
Consolidated Net Profit ₹260 Cr₹300 Cr₹164 Cr₹64 Cr₹81 Cr
Earnings Per Share (Rs)₹202.74₹233.89₹127.45₹49.74₹62.85
PAT Margin (%)17.6119.2513.736.718.61
ROE(%)18.5426.3817.847.8510.79
ROCE(%)23.4533.5120.949.4412.81
Total Debt/Equity(x)0.090.060.120.280.22

Key Financials

Market Cap : ₹ 17,583.0 Cr
Revenue (TTM) : ₹ 1,476.8 Cr
Net Profit(TTM) : ₹ 260.1 Cr
EPS (TTM) : ₹ 203.2
P/E (TTM) : 67.6

Industry Peers & Returns1W1M1Y
NEULAND LABORATORIES -2.9% 14.8% 64.8%
SUN PHARMACEUTICAL INDUSTRIES 0.4% 1.8% 4.5%
DIVIS LABORATORIES -1.1% 0.1% 45.6%
CIPLA 3.8% 1.2% -1.1%
TORRENT PHARMACEUTICALS 2.2% 11.7% 11.7%
DR REDDYS LABORATORIES 1.4% -3.3% -7.2%
MANKIND PHARMA -1.7% 13% 22.9%
ZYDUS LIFESCIENCES 0.7% -0.6% -17.7%
LUPIN 1.5% 1.3% 7%


NEULAND LABORATORIES Revenues
[BOM: 524558|NSE : NEULANDLAB]

Y-o-Y

-5.24 %

5 Yr CAGR

12.05 %

Years Revenues % Change
Mar2025 ₹1,477 Cr
-5.24
Mar2024 ₹1,559 Cr
30.84
Mar2023 ₹1,191 Cr
25.25
Mar2022 ₹951 Cr
1.51
Mar2021 ₹937 Cr -


NEULAND LABORATORIES Operating Profit
[BOM: 524558|NSE : NEULANDLAB]

Y-o-Y

-30.12 %

5 Yr CAGR

21.81 %

Years Operating Profit % Change
Mar2025 ₹323 Cr
-30.12
Mar2024 ₹463 Cr
70.17
Mar2023 ₹272 Cr
90.61
Mar2022 ₹143 Cr
-2.86
Mar2021 ₹147 Cr -

Operating Margins
Y-o-Y

-26.25 %

5 Yr CAGR

8.72 %

Years Operating Margin% % Change
Mar2025 21.89%
-26.25
Mar2024 29.68%
30.06
Mar2023 22.82%
52.13
Mar2022 15%
-4.28
Mar2021 15.67% -

NEULAND LABORATORIES Profit After Tax
[BOM: 524558|NSE : NEULANDLAB]

Y-o-Y

-13.32 %

5 Yr CAGR

34.02 %

Years Profit After Tax % Change
Mar2025 ₹260 Cr
-13.32
Mar2024 ₹300 Cr
83.51
Mar2023 ₹164 Cr
156.21
Mar2022 ₹64 Cr
-20.85
Mar2021 ₹81 Cr -

PAT Margins
Y-o-Y

-8.52 %

5 Yr CAGR

19.59 %

Years PAT Margin(%) % Change
Mar2025 17.61 %
-8.52
Mar2024 19.25 %
40.20
Mar2023 13.73 %
104.62
Mar2022 6.71 %
-22.07
Mar2021 8.61 % -

NEULAND LABORATORIES Earnings Per Share (EPS)
[BOM: 524558|NSE : NEULANDLAB]

Y-o-Y

-13.32 %

5 Yr CAGR

34.02 %

Years EPS % Change
Mar2025 ₹203
-13.32
Mar2024 ₹234
83.52
Mar2023 ₹127
156.23
Mar2022 ₹50
-20.86
Mar2021 ₹63 -

NEULAND LABORATORIES Return on Capital Employed (ROCE)
[BOM: 524558|NSE : NEULANDLAB]

Y-o-Y

-30.02 %

5 Yr CAGR

16.32 %

Years ROCE % Change
Mar2025 23.45%
-30.02
Mar2024 33.51%
60.03
Mar2023 20.94%
121.82
Mar2022 9.44%
-26.31
Mar2021 12.81% -

NEULAND LABORATORIES Share Price vs Sensex

Current Share Price : ₹13,736.7
Current MarketCap: ₹ 17,583.0 Cr
Updated EOD on :Jul 25,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-2.9%

14.8%

64.8%

SENSEX

-0.4%

-1.6%

1.3%

NEULAND LABORATORIES related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE 500 SHARIAH 4.3% 4.3% 1.1%
BSE HEALTHCARE 0.5% 4% 17%
BSE 500 -1.1% -1.1% 0%
NSE Indices1W1M1Y
NIFTY MIDSMALL HEALTHCARE 0.7% 6.8% 22.2%
NIFTY 500 -1.1% -1.2% 0.7%
NIFTY500 MULTICAP INDIA MANUFACTURING 50:30:20 -1.2% 0.4% 1.3%
NIFTY TOTAL MARKET -1.2% -1.2% 0.7%
NIFTY500 MULTICAP 50:25:25 -1.5% -1% 1.2%

You may also like the below Video Courses


FAQ about NEULAND LABORATORIES Financials


How the annual revenues of NEULAND LABORATORIES have changed ?

The Revenues of NEULAND LABORATORIES have decreased by -5.24% YoY .

How the Earnings per Share (EPS) of NEULAND LABORATORIES have changed?

The Earnings Per Share (EPS) of NEULAND LABORATORIES has decreased by -13.32 % YoY .